Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Oncogenic RAS: From Its Activation to Its Direct Targeting

Volumen 22, Edición 3-4, 2017, pp. 283-301
DOI: 10.1615/CritRevOncog.2017024695
Get accessGet access

SINOPSIS

The RAS oncogenes are the most commonly mutated genes across human cancers. This review is a look back at the discovery of the RAS genes, how we came to understand their function, and how these oncogenes are aberrantly activated, driving cancer development and growth. It also highlights the comprehensive efforts made during the last 30 years to develop therapeutic strategies against the oncogenic mutant RAS. Although there have been many lost battles in the war against mutant RAS-bearing cancer cells, and we have yet to determine which is the "best" path for inhibition of the mutated RAS, a better understanding of the protein's structure combined with technological advances in the field has allowed the development of new strategies to make anti-RAS therapies a reality. The state-of-the-art for each strategy is discussed, focusing on the promises and potential pitfalls of each of them.

CITADO POR
  1. Dabaja Mohamed Ziad, dos Santos Aline Amaro, Christofolini Denise Maria, Barbosa Caio Parente, de Oliveira Diogo Noin, de Oliveira Arthur Noin, Melo Carlos Fernando Odir Rodrigues, Guerreiro Tatiane Melina, Catharino Rodrigo Ramos, Comparative metabolomic profiling of women undergoing in vitro fertilization procedures reveals potential infertility-related biomarkers in follicular fluid, Scientific Reports, 12, 1, 2022. Crossref

3845 Vistas de artículos 34 Descargas de artículos Métrica
3845 PUNTOS DE VISTA 34 DESCARGAS 1 Crossref CITAS Google
Scholar
CITAS

Artículos con contenido similar:

Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer Journal of Environmental Pathology, Toxicology and Oncology, Vol.42, 2023, issue 4
Md. Abubakar, Ahsas Goyal, V. G. M. Naidu, Gaurav Gupta, Vetriselvan Subramaniyan, Waleed Hassan Almalki, Ch. Veera Bhadrawamy, S. Roshan, Fahim Anwar Rizwi, Sushama Rawat, Eswara Rao Puppala, B. Tazneem
A Comprehensive Review of Diagnostic and Therapeutic Strategies for the Management of Pancreatic Cancer Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 4
Atul K. Tiwari, Tamanna Walia, Naveen Kumar Vishvakarma, Dhananjay Shukla, Sapnita Shinde, Saurabh Saxena, Vibha Sinha, Vineeta Dixit, Suresh Thakur, Mrigendra Dwivedi
Genomic Alterations to Guide Treatment Selection in Metastatic Prostate Cancer Critical Reviews™ in Oncogenesis, Vol.27, 2022, issue 1
Amy Davies, Arun A. Azad, Edmond M. Kwan
Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 2
Afroz Alam, Begum Dariya, Sheik Aliya, Neha Merchant, Ganji Purnachndra Nagaraju
Cancer Nanotechnology in Medicine: A Promising Approach for Cancer Detection and Diagnosis Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.37, 2020, issue 4
Rajeev Mishra, Abhijeet Singh, Bjorn John Stephen, Surabhi Suchanti
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain